Applied Nanoscience Invited to Present at the U.S. Department of Health and Human Services on NanoFense(TM) Formulation CARLSBAD, CA--(MARKET WIRE)--Mar 18, 2009 -- Applied Nanoscience Inc. (ANI) (Other OTC:APNN.PK - News), a nanotechnology-based
filtration development company, today
announced that it has accepted an invitation from the U.S.
Department of
Health and Human Services to present on its core technology,
NanoFense, a
proprietary antimicrobial nanoparticle formulation developed
by ANI to coat
or impregnate virtually any air filter media. The material
presented will
specifically focus on protective and surgical mask applications
and
comprehensively cover the company's successful independent
testing against
avian influenza and other harmful pathogens. "We are excited and flattered to have this opportunity in sharing our continued technology developments with such an important organization. DHHS is certainly qualified to offer constructive advice on ANI's primary objective of proactively protecting people from harmful disease," said Thomas K. Allen, President and CEO, ANI. "In addition, we hope to progress in making the technology widely available to consumers with the guidance provided at the meeting." About ANI ANI is a marketer and developer of innovative, high performance nanotechnology-based filtration products to customers worldwide and is the owner of NEFT(TM) (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential in consumer market segments. For further information about Applied Nanoscience Inc., please visit: www.appliednanoscience.com Safe Harbor Statement This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements. Contact: Contact:
Philippe Niemetz
800-477-7570 or 212-344-6464
p.niemetz@panconsultants.com
Investor Relations
PAN Consultants Ltd.
Source: Applied Nanoscience, Inc.
|